AI assistant
STAAR SURGICAL CO — Director's Dealing 2014
Mar 20, 2014
31996_dirs_2014-03-19_0b556e8d-d730-44ff-ae34-57604619c7d6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2014-03-19
Reporting Person: Francese James E (VP, Global Marketing)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-03-19 | Common Stock | M | 16666 | $6.71 | Acquired | 38626 | Direct |
| 2014-03-19 | Common Stock | S | 16666 | $17.2242 | Disposed | 21960 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-03-19 | Common Stock Options | $6.71 | M | 16666 | Disposed | 2022-09-03 | Common Stock (16666) | Direct |
Footnotes
F1: Includes 7,500 Performance Accelerated Restricted Shares of Common Stock (PARS), subject to forfeiture rights, which lapse on 3/4/16. Also includes 7,000 Restricted Shares of Common Stock (RSU), subject to forfeiture rights, which lapses as to 1/2 of the shares (3500 shares) on 3/7/16 and lapses as to the other 1/2 of the shares (3500 shares) on 3/7/17.
F2: The 50,000 options originally granted become exercisable as follows: 16,666 on September 4, 2013, 16,666 on September 4, 2014, and 16,667 on September 4, 2015.
F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.11 to $17.31, inclusive.